R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms

被引:148
作者
Kawamura, T
Gulden, FO
Sugaya, M
McNamara, DT
Borris, DL
Lederman, MM
Orenstein, JM
Zimmerman, PA
Blauvelt, A
机构
[1] Case Western Reserve Univ, AIDS Res Ctr, Dept Med, Cleveland, OH 44195 USA
[2] Univ Hosp Cleveland, Cleveland, OH 44195 USA
[3] NCI, Canc Res Ctr, Dermatol Branch, Bethesda, MD 20892 USA
[4] George Washington Univ, Dept Pathol, Washington, DC 20037 USA
关键词
D O I
10.1073/pnas.1432450100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Langerhans cells (LCs) are suspected to be initial targets for HIV after sexual exposure (by becoming infected or by capturing virus). Here, productive R5 HIV infection of LC ex vivo and I-C-mediated transmission of virus to CD4(+) T cells were both found to depend on CCR5. By contrast, infection of monocyte-derived dendritic cells and transfer of infection from monocyte-derived dendritic cells to CD4+ T cells were mediated by CCR5-dependent as well as DC-specific ICAM-3-grabbing nonintegrin-dependent pathways. Furthermore, in 62 healthy individuals, R5 HIV infection levels in LCs ex vivo were associated with CCR5 genotype. Specifically, genotyping for ORFDelta32 revealed that LCs isolated from ORFDelta32/wt individuals were significantly less susceptible to HIV when compared with LCs isolated from ORFwt/wt individuals (P = 0.016). Strikingly, further genetic analyses of the A-2459G CCR5 promoter polymorphism in ORFDelta32/wt heterozygous individuals revealed that LCs isolated from -2459A/G + ORFDelta32/wt individuals were markedly less susceptible to HIV than were LCs from -2459A/A + ORFDelta32/wt individuals (P = 0.012). Interestingly, these genetic susceptibility data in LCs parallel those of genetic susceptibility studies performed in cohorts of HIV-infected individuals. Thus, we suggest that CCR5-mediated infection of LCs, and not capture of virus by LCs, provides a biologic basis for understanding certain aspects of host genetic susceptibility to initial HIV infection.
引用
收藏
页码:8401 / 8406
页数:6
相关论文
共 48 条
[1]
Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans [J].
An, P ;
Martin, MP ;
Nelson, GW ;
Carrington, M ;
Smith, MW ;
Gong, K ;
Vlahov, D ;
O'Brien, SJ ;
Winkler, CA .
AIDS, 2000, 14 (14) :2117-2122
[2]
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C [J].
Ball, SC ;
Abraha, A ;
Collins, KR ;
Marozsan, AJ ;
Baird, H ;
Quiñones-Mateu, ME ;
Penn-Nicholson, A ;
Murray, M ;
Richard, N ;
Lobritz, M ;
Zimmerman, PA ;
Kawamura, T ;
Blauvelt, A ;
Arts, EJ .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1021-1038
[3]
Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences [J].
Carrington, M ;
Dean, M ;
Martin, MP ;
O'Brien, SJ .
HUMAN MOLECULAR GENETICS, 1999, 8 (10) :1939-1945
[4]
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[5]
AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor [J].
Donzella, GA ;
Schols, D ;
Lin, SW ;
Esté, JA ;
Nagashima, KA ;
Maddon, PJ ;
Allaway, GP ;
Sakmar, TP ;
Henson, G ;
De Clercq, E ;
Moore, JP .
NATURE MEDICINE, 1998, 4 (01) :72-77
[6]
Transepithelial transport of HIV-1 by M cells is receptor-mediated [J].
Fotopoulos, G ;
Harari, A ;
Michetti, P ;
Trono, D ;
Pantaleo, G ;
Kraehenbuhl, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (14) :9410-9414
[7]
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[8]
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes [J].
Gonzalez, E ;
Bamshad, M ;
Sato, N ;
Mummidi, S ;
Dhanda, R ;
Catano, G ;
Cabrera, S ;
McBride, M ;
Cao, XH ;
Merrill, G ;
O'Connell, P ;
Bowden, DW ;
Freedman, BI ;
Anderson, SA ;
Walter, EA ;
Evans, JS ;
Stephan, KT ;
Clark, RA ;
Tyagi, S ;
Ahuja, SS ;
Dolan, MJ ;
Ahuja, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (21) :12004-12009
[9]
Global survey of genetic variation in CCR5, RANTES, and MIP-1α:: Impact on the epidemiology of the HIV-1 pandemic [J].
Gonzalez, E ;
Dhanda, R ;
Bamshad, M ;
Mummidi, S ;
Geevarghese, R ;
Catano, G ;
Anderson, SA ;
Walter, EA ;
Stephan, KT ;
Hammer, MF ;
Mangano, A ;
Sen, L ;
Clark, RA ;
Ahuja, SS ;
Dolan, MJ ;
Ahuja, SK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5199-5204
[10]
Towards a molecular understanding of dendritic cell immunobiology [J].
Hartgers, FC ;
Figdor, CG ;
Adema, GJ .
IMMUNOLOGY TODAY, 2000, 21 (11) :542-545